Home > Healthcare > Medical Devices > Diagnostic Devices > Urinary Tract Infection Testing Market

Urinary Tract Infection Testing Market Trends

Report ID: GMI5628
Published Date: May 2023
Report Format: PDF

Download Free Sample

Urinary Tract Infection Testing Market Trends

Prominent industry players are continuously focusing on product innovation with integration of advanced technologies. Such developments are aimed towards offering simplified and convenient diagnostic test types. Innovations in test kit types will have a positive impact on urinary tract infection testing business expansion. For instance, in August 2022, TestCard announced the launch of a non-invasive home testing kit in UK for the detection of UTI. In addition, it is a smartphone enabled UTI test that allows users to detect UTI through immediate testing results.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for urinary tract infection testing was over USD 590 million in 2022 and will reach over USD 1 billion by 2032.

Hospitals segment will record over USD 450 million by 2032 due to rising cases of UTIs and awareness about UTI testing.

North America UTI testing market size will be more than USD 400 million by 2032 on account of ongoing technological developments for the early detection of UTI.

Thermo Fisher Scientific, Inc., Danaher Corporation, Stryker Corporation, ACON Laboratories Inc., Bio-Rad Laboratories, Cardinal Health Inc., and Abbott Laboratories are the leading providers of urinary tract infection testing.